Skip Ribbon Commands
Skip to main content
Sign In
{{'GLOBAL_MESSAGE_HEADLINE' | translate}}
{{'GLOBAL_MESSAGE_CHOOSE_LANG' | translate}}
en
日本語
中文
{{'GLOBAL_MESSAGE_OR' | translate}}
{{'GLOBAL_MESSAGE_SET_COUNTRY' | translate}}
{{'ELOQUA_BANNER_DECLINE_CONFIRM' | translate}}
{{'ELOQUA_BANNER_DECLINE_CONFIRM_CLOSE' | translate}}
{{'ELOQUA_BANNER_ACCEPT' | translate}}
{{'ELOQUA_BANNER_DECLINE' | translate}}
Executive Leadership

Leading Our Way

Antoinette Gawin
President and Chief Executive Officer

Antoinette Gawin is President and Chief Executive Officer of Terumo Blood and Cell Technologies, a mission-driven medical device company that is focused on unlocking the potential of blood and cell-based therapies. The innovative company strives to advance healthcare, broaden treatment options and improve patient outcomes through its technologies within the sectors of blood banking, transfusion medicine and regenerative medicine.

Antoinette focuses on how the company will continue to evolve with healthcare’s rapid changes to meet more patients' needs globally. She believes medical device manufacturers must change and go beyond equipment to think about services, data management and new geographies where people do not yet have access to the technologies that can advance their health and lives. Antoinette is ensuring that Terumo Blood and Cell Technologies continues to focus on service and helping our customers solve problems — enabling them to better serve patients.

She has nearly 30 years of experience directing diverse global teams and transformational change. Building from a foundation in finance, operations and customer service, Antoinette has led joint ventures and acquisitions, as well as all aspects of marketing, strategic planning and commercial operations for divisions of companies in the healthcare, information technology and energy sectors.

Antoinette joined the company in 2016 and previously served as Executive Vice President, Global Commercial. She was responsible for leading the company’s global sales, services, marketing and commercial teams.

In her past leadership roles at Baxter Healthcare, she oversaw global market access and commercial excellence, strategy and commercial operations. For more than 20 years prior, Antoinette worked at GE Corporate and a number of subsidiaries, including GE Healthcare Technologies, GE Industrial and Power Systems and GE Information Services.

She is a member of the AdvaMed Board of Directors and serves as the chair of the AdvaMed Ethics and Compliance Committee.

Antoinette is involved in many civic organizations, including American Friends of Watershed Trust Organization, a nonprofit focused on sustainable access to clean water in India. She lives with her family in Colorado, where they enjoy the outdoors and the performing arts.

Rebecca Bortolotti
Senior Vice President, General Counsel

Rebecca Bortolotti serves as Senior Vice President, General Counsel for Terumo Blood and Cell Technologies, a mission-driven medical technology company focused on unlocking the potential of blood and cell-based therapies. In this capacity, Rebecca leads the global Legal, Compliance and Government Affairs functions for the company. She is a member of the company’s Executive Management Committee.

She has extensive leadership experience across several industries with a science and technology focus, including agricultural biotechnology and consumer foods. Prior to joining Terumo Blood and Cell Technologies, Rebecca served as the General Counsel and Corporate Secretary for Benson Hill Inc., where she established the Legal and Compliance function. Before joining Benson Hill, Rebecca was Vice President and Chief Technology Counsel at ConAgra Brands Inc.

Rebecca holds undergraduate degrees in biology and German from the University of South Dakota and graduated magna cum laude from Creighton University School of Law. She is also a registered patent attorney.

She and her husband currently live in Omaha, Nebraska, and together they have three children. She enjoys water activities and the ocean and is learning to love the mountains.

Rusty Spinney
Executive Vice President, Chief Financial Officer

As Chief Financial Officer and Executive Vice President, Rusty Spinney has worldwide responsibility for all finance functions at Terumo Blood and Cell Technologies. Rusty oversees accounting, tax, treasury, finance, and planning and analysis.

Rusty also serves as a corporate liaison with Terumo Corporation, aligning budgeting, forecasting, month-end and quarter-end reporting processes, strategic plan financials and all other financial matters, including meeting requirements for Japan's equivalent of the Sarbanes-Oxley Act.

Rusty's expertise spans corporate finance, governance and policy, capital markets, international business and Sarbanes-Oxley Act implementation, as well as mergers, acquisitions and business integration.

Prior to his current role, Rusty held the position of Vice President of Finance and Corporate Controller, in which he was responsible for global financial reporting, technical accounting and financial controls across all world regions. Prior to joining Terumo Blood and Cell Technologies, he held leadership and financial management positions at Quiznos Inc. and Molson Coors, and he served as the European controller for Bass Brewing operations, based in England. He also provided business and advisory services for PricewaterhouseCoopers.

Rusty earned his bachelor's degree in business finance from Colorado State University.

Veerle d’Haenens
General Manager, Therapeutic Systems, Terumo Blood and Cell Technologies

As head of the Therapeutic Systems business unit, Veerle leads a cross-functional team transforming business models and solutions to meet the changing needs of our global customers and patients. This includes translating strategy into practical approaches to reach more patients with our products and capturing real-time insights for a diverse and comprehensive portfolio. 

Veerle’s interest in healthcare comes from her passion to make a meaningful contribution to society. She believes that working with a diverse, engaged team behind clearly defined goals drives results that enable more patients to get access to healthcare and better treatment options.

She has worked in healthcare for more than 20 years, across the pharmaceutical and medical device sectors in a variety of sales and marketing leadership roles. With this experience and perspective, she inspires and mobilizes people and teams around a clear vision and strategy.

Veerle previously served as Vice President, Commercial, EMEA. She was also the Commercialization Director for EMEA Therapeutics Systems, where she successfully repositioned the business across Europe as a partner to provide clinical solutions and disease therapies. She joined the company in 2010 as a Sales Manager.

Before joining Terumo Blood and Cell Technologies, she worked at Pfizer in various business units, most recently as the Business Unit Director, Rheumatology and Dermatology.

She graduated with distinction from the University of Leuven. Her engineering degree focused on a specialization for chemical and agriculture industries, including industrial biology and microbiology, as well as cell and gene technology.

Dr. Cynthia Hougum
Senior Vice President & General Manager, Plasma Innovations

Cynthia Hougum serves as Senior Vice President & General Manager of Plasma Innovations for Terumo Blood and Cell Technologies, a mission-driven medical device company focused on unlocking the potential of blood and cell-based therapies. She has 25 years of enterprise leadership experience serving in general management and executive leadership roles at Terumo along with GE’s Plastics, Healthcare and Life Sciences businesses. This has included leading multiple acquisitions, launching new products, leading global engineering teams and digital transformation of plant operations.

Her foundational experiences as a customer-facing scientist delivering high-quality products, growing businesses organically and inorganically, plus having strong global experience leading teams in eight countries, uniquely positions her with the development of this new sourced plasma business market.

Cynthia holds a PhD in physical-organic chemistry from Duke University and a bachelor’s degree in chemistry from Viterbo University, La Crosse, WI.

Bon Lopez
Senior Vice President, Human Resources

Bon Lopez serves as Senior Vice President, Human Resources for Terumo Blood and Cell Technologies, a medical device company with products, software and services that enable customers to collect and prepare blood and cells to help treat challenging diseases and conditions.

Bon has more than 25 years of international business experience in the consumer-packaged goods, consumer healthcare and diagnostics/medical devices industries across the Americas, Europe and Asia in organizations such as Unilever, Novartis and Ortho Clinical Diagnostics. He has held multiple human resources leadership positions and is an expert in talent, organizational and leadership development.

Bon earned his bachelor’s degree in commerce at De La Salle University, Philippines. He has completed several executive education programs in human resources, business and strategy at the business schools of Stanford University, Babson College and Dartmouth College. For two decades, Bon has partnered with leaders as a certified executive coach. He enjoys traveling with his family and exploring new countries and cultures. In his spare time, he plays basketball and competitive badminton as well as mentoring young leaders across the world.

Chetan Makam
General Manager, Blood Center Solutions

Chetan Makam serves as General Manager, Blood Center Solutions for Terumo Blood and Cell Technologies, a mission-driven medical technology company focused on unlocking the potential of blood and cell-based therapies. He is the Board Chair for Terumo Penpol, Pvt., Ltd., a subsidiary of Terumo Blood and Cell Technologies. Chetan is also Terumo Penpol’s Managing Director with accountability for our India operations and businesses.

As a key member of Terumo’s executive leadership team, Chetan leads a globally integrated service team that currently serves as a key market differentiator in 130 different countries and aims to deliver a unified customer experience. In addition to leading Global Services, he co-leads the Digital Transformation and Data Analytics programs and is accountable for the Process Excellence initiatives.

Chetan brings over 25 years of experience in the medical device, healthcare and other industries. His experience includes creating and running businesses, general management, strategic marketing, product management, sales and new business development, management consulting, operational excellence, R&D and operations. Having worked in various parts of the world, he brings a unique perspective and understanding of various cultures and people.

He has an MBA (cum laude) from Babson College, an M.S. in plastics engineering from the University of Massachusetts, and a B.S. (Gold Medalist) in polymer engineering from the University of Poona, India, and is a certified LEAN Six Sigma Master Blackbelt.

Chetan is an avid reader and an amateur numismatist. He is based in Colorado.

Delara Motlagh, PhD, MBA
General Manager, Cell Therapy Technologies

Delara Motlagh is General Manager, Cell Therapy Technologies at Terumo Blood and Cell Technologies, a mission-driven medical technology company focused on unlocking the potential of blood and cell-based therapies. She is passionate about the cell and gene therapy market and the potential these innovative therapies hold to improve the lives of patients.

She brings more than 18 years of experience in biotechnology and healthcare in various therapeutic areas including oncology, cardiology, orthopedics, hematology and nephrology.

Prior to joining Terumo Blood and Cell Technologies in 2017, Delara served in diverse leadership roles at Baxter Healthcare in marketing, research and development and operations. Her cross-functional background provides a unique perspective and deep understanding of development, cell manufacturing and commercialization elements in the industry.

Delara hold a PhD in physiology and biophysics from the University of Illinois, a fellowship in vascular tissue engineering at Northwestern University and an Executive MBA from the Kellogg School of Management. 

Cindy Ng
Senior Vice President, Global Commercial

Cindy Ng serves as Senior Vice President, Global Commercial for Terumo Blood and Cell Technologies, a mission-driven medical device company focused on unlocking the potential of blood and cell-based therapies. The innovative medical device company strives to advance patient care, broaden treatment options and improve patient outcomes through its technologies within the sectors of blood banking, transfusion medicine and regenerative medicine.

As a member of the leadership team, Cindy is responsible for front-line interactions with the company’s customers globally. This includes sales, services, clinical support, distributor management, and regional and local marketing to deliver high-impact customer experiences and a world-class presence at the local level.

Cindy is a hands-on sales and marketing practitioner with more than 25 years of experience in the pharmaceutical and medical device industry. Her commercial experience includes both direct and distributor sales and marketing roles with Roche, 3M and Sanofi. She transitioned to medical devices with Advanced Medical Optics (part of Abbott) and Pall Corporation. After Danaher Corp.’s acquisition of Pall Corp., she took on a new challenge to turn around its biopharmaceuticals business in China.

Gene Stellon
Senior Vice President, Innovation and Development

Gene Stellon serves as Senior Vice President, Innovation and Development (I&D) for Terumo Blood and Cell Technologies, a mission-driven medical technology company focused on unlocking the potential of blood and cell-based therapies. He is a member of the company’s Executive Management Committee.

Gene has extensive leadership experience across the military and private sectors with a focus on quality assurance, engineering, innovation and medical technology. Prior to joining Terumo Blood and Cell Technologies, he worked for Medtronic, where he served as the Vice President, Research and Development (R&D) Surgical Energy & Safety and Gynecological Health (GYN) within Surgical Innovations.

Throughout his career, Gene has held successive leadership roles in R&D, including as a manufacturing engineer at US Surgical, where he supported access and ligation devices along with surgical staplers. Gene served in the U.S. Air Force and the Connecticut Air National Guard, retiring in 2015.

Gene holds degrees in electrical engineering, criminal justice and industrial technology. He obtained his MBA from Southern Connecticut. He holds 47 issued patents.

He currently resides in Burlington, Con., with his wife, Mary. He has two children, Michael and Alexandra, and a dachshund, Munson. Gene enjoys travel and the outdoors including hunting, fishing, hiking and skiing.

John Tanner
Strategy Leader

John serves as the Strategy Leader for Terumo Blood and Cell Technologies, a mission-driven medical technology company focused on unlocking the potential of blood and cell-based therapies. He is responsible for partnering with the Executive Team and other business leaders to develop the broad and global strategic vision and the long-term business plan for the company. John’s focus is identifying and evaluating new growth opportunities.

He brings extensive experience in strategic planning and market development in the medical technology industry. His past includes over 20 years of management experience at publicly traded companies, advanced technology startups and strategy consulting firms. Throughout John’s career, his focus has been bringing both mature and innovative medical technologies to new patient populations.

Previously, John was the CEO of an infectious disease diagnostic startup. He also served as a Vice President and part of the Senior Leadership Team at Edwards Lifesciences, where he held positions of increasing responsibility in corporate strategy, strategic and product marketing, therapy development and sales management. John has led more than 60 engagements as a management consultant at L.E.K. Consulting and other leading advisory firms.

He earned an MBA in finance, with high honors, from the University of Chicago.

Chris Williams
Senior Vice President, Global Manufacturing

Chris Williams serves as Senior Vice President, Global Manufacturing for Terumo Blood and Cell Technologies, a mission-driven medical device company focused on unlocking the potential of blood and cell-based therapies. Chris leads the manufacturing, supply chain, logistics and procurement teams.

He developed deep manufacturing experience through progressively responsible roles at Baxter, including rebuilding facilities and launching countless engineering and continuous improvement programs. He led Baxter’s European manufacturing operations, delivering dramatic cost, quality and customer service improvements.

Chris’s experience building lean, customer-focused manufacturing organizations enabled him then to transform the manufacturing infrastructure for Salter Labs and Santa Cruz Nutritionals before serving as vice president of manufacturing operations at PharMEDium Services. His foundation of process improvement and ability to build cultural bridges are skills he is using to enable teams to further Terumo Blood and Cell Technologies’ continued growth.

Chris holds a bachelor’s degree in industrial engineering from Mississippi State University. He is an avid tennis player and loves to travel in his free time.

​​​​​​​​​​​​​​​​​​​​​​​​​​​​​

{{'SEARCH_MODAL_TITLE' | translate }}
{{'SEARCH_MODAL_OR' | translate }}

{{'SEARCH_MODAL_BROWSE' | translate }} {{'SEARCH_MODAL_ENLABEL' | translate }}
{{'SEARCH_MODAL_CHOOSE_LANGUAGE' | translate }} {{'SEARCH_MODAL_CHANGE_LANGUAGE' | translate }}
{{$index+1}}. {{s.label}}